HRMY - Harmony Biosciences Holdings Inc
IEX Last Trade
36.005
0.255 0.708%
Share volume: 168,747
Last Updated: Fri 30 Aug 2024 09:59:49 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$35.75
0.26
0.71%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-01 | 2023-02-21 | 2023-05-02 | 2023-08-01 | 2023-10-31 | 2024-02-22 | 2024-04-30 | |
| Assets | |||||||||
| Total Assets | 505.034 M | 643.464 M | 673.870 M | 715.092 M | 760.183 M | 777.766 M | 811.448 M | 846.985 M | |
| Current Assets | 322.702 M | 382.082 M | 400.285 M | 418.087 M | 455.641 M | 462.998 M | 451.070 M | 479.503 M | |
| Inventories | 4.208 M | 3.900 M | 4.297 M | 4.090 M | 4.854 M | 5.087 M | 5.363 M | 5.857 M | |
| Other Current Assets | 14.501 M | 15.354 M | 18.133 M | 17.544 M | 15.992 M | 19.973 M | 18.107 M | 21.577 M | |
| Short Term Investments | 14.501 M | 15.354 M | 18.133 M | 17.544 M | 15.992 M | 19.973 M | 18.107 M | 21.577 M | |
| Total Receivables | 49.822 M | 55.065 M | 54.740 M | 52.575 M | 63.812 M | 67.264 M | 74.140 M | 79.719 M | |
| Current Cash | 254.171 M | 307.763 M | 323.115 M | 343.878 M | 370.983 M | 370.674 M | 353.460 M | 372.350 M | |
| Total Non-current Assets | 182.332 M | 261.382 M | 273.585 M | 297.005 M | 304.542 M | 314.768 M | 360.378 M | 367.482 M | |
| Property Plant Equipment | 695.000 K | 680.000 K | 573.000 K | 470.000 K | 572.000 K | 428.000 K | 371.000 K | 213.000 K | |
| Other Assets | 3.264 M | 3.079 M | 2.798 M | 2.870 M | 2.460 M | 2.836 M | 6.298 M | 6.969 M | |
| Intangible Assets | 172.876 M | 166.914 M | 160.953 M | 154.992 M | 149.031 M | 143.069 M | 137.108 M | 131.147 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 505.034 M | 643.464 M | 673.870 M | 715.092 M | 760.183 M | 777.766 M | 811.448 M | 846.985 M | |
| Total liabilities | 258.501 M | 299.580 M | 271.032 M | 272.051 M | 275.011 M | 296.434 M | 344.456 M | 331.591 M | |
| Total current liabilities | 65.764 M | 107.357 M | 78.884 M | 85.363 M | 93.045 M | 112.408 M | 163.781 M | 154.253 M | |
| Accounts Payable | 6.661 M | 10.049 M | 3.786 M | 6.414 M | 6.563 M | 6.539 M | 17.730 M | 15.144 M | |
| Other liabilities | 2.930 M | 2.498 M | 2.501 M | 1.625 M | 1.479 M | 1.895 M | 2.109 M | 2.342 M | |
| Current long term debt | 2.000 M | 2.000 M | 2.000 M | 6.500 M | 11.000 M | 15.000 M | 15.000 M | 15.000 M | |
| Long term debt | 189.807 M | 189.725 M | 189.647 M | 185.063 M | 180.487 M | 182.131 M | 178.566 M | 174.996 M | |
| Other liabilities | 2.930 M | 2.498 M | 2.501 M | 1.625 M | 1.479 M | 1.895 M | 2.109 M | 2.342 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 246.533 M | 343.884 M | 402.838 M | 443.041 M | 485.172 M | 481.332 M | 466.992 M | 515.394 M | |
| Common stock | 59.063 M | 59.235 M | 59.486 M | 59.732 M | 59.974 M | 59.863 M | 58.309 M | 56.771 M | |
| Retained earnings | -408.582 M | -320.639 M | -272.130 M | -242.645 M | -208.345 M | -169.884 M | -143.277 M | -104.943 M |